Biotech

All Articles

Zephyrm finds Hong Kong IPO to finance period 3 cell therapy trials

.Zephyrm Bioscience is gusting toward the Hong Kong stock market, declaring (PDF) for an IPO to mone...

Frazier Life Sciences gets $630M for tiny, mid-cap biotechs

.Frazier Daily life Sciences has sourced an additionally $630 thousand for its fund concentrated on ...

GigaGen garners around $135M BARDA dollars to beat botox

.Antibody fan GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its own technology t...

GPCR firm Septerna files for IPO on toughness of preclinical records

.Septerna is about to learn exactly how a biotech without "any relevant clinical data" meals in the ...

Kurma finalizes initially $154M payload for greatest biotech fund yet

.International VC organization Kurma Allies has actually introduced its own most current biotech fun...

Prothena markets one director while an additional keeps-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings ...

Editas profit Tip Cas9 licensing rights for $57M

.Against the backdrop of a Cas9 license battle that declines to die, Editas Medication is moneying i...

Ultragenyx tweaks genetics therapy application to dial up efficiency

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson health condition gene therapy UX70...

Biopharma unemployment price stabilizes in Q3: Fierce Biotech analysis

.As summertime warm relies on cool down winds, really hopes that this year will bring wide-spread se...

J &amp J loses stage 2 dengue prospect in most current change coming from vaccinations

.Johnson &amp Johnson's deprioritization of its infectious ailment pipeline has claimed one more vic...